UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19

JAMA : the journal of the American Medical Association, 2021-04, Vol.325 (15), p.1525

2021

Volltextzugriff (PDF)

Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression

Psychiatry research, 2015-12, Vol.230 (2), p.682-688

2015

Volltextzugriff (PDF)

Short‐term acceptability by patients and psychiatrists of the turn to psychiatric teleconsultation in the context of the COVID‐19 pandemic

Psychiatry and clinical neurosciences, 2020-08, Vol.74 (8), p.443-444

2020

Volltextzugriff (PDF)

Efficacy and safety of adjunctive vagus nerve stimulation in the treatment of resistant depression with psychotic features: A case report

Brain stimulation, 2021-05, Vol.14 (3), p.498-499

2021

Volltextzugriff (PDF)

Dramatic and Rapid Resolution of Both Psychosis and Neuroleptic-Related Catatonia With Zolpidem in a Patient With Systemic Lupus Erythematosus

Journal of clinical psychopharmacology, 2019-09, Vol.39 (5), p.509-511

2019

Volltextzugriff (PDF)

Neurobiological Approach of Catatonia and Treatment Perspectives

Frontiers in psychiatry, 2015-12, Vol.6, p.182-182

2015

Volltextzugriff (PDF)

Meta-analysis of central and peripheral γ-aminobutyric acid levels in patients with unipolar and bipolar depression

Journal of psychiatry & neuroscience, 2018-01, Vol.43 (1), p.58-66

2018

Volltextzugriff (PDF)

Comorbidity of long COVID and psychiatric disorders after a hospitalisation for COVID-19: a cross-sectional study

Journal of neurology, neurosurgery and psychiatry, 2022-10, Vol.93 (10), p.1091-1098

2022

Volltextzugriff (PDF)

Anosmia during acute COVID-19 and psychiatric outcomes 4 months later: Results from the prospective COMEBAC cohort

General hospital psychiatry, 2023-09, Vol.84, p.260-261

2023

Volltextzugriff (PDF)

P124. Which Patients Will Have Mental Disorders After Hospitalization for COVID-19?

Biological psychiatry (1969), 2022-05, Vol.91 (9), p.S137-S137

2022

Volltextzugriff (PDF)

Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial

Lancet neurology, 2012-07, Vol.11 (7), p.589-596

2012

Volltextzugriff (PDF)

Intra-nasal esketamine induced psychotic disorder in a post COVID-19 major depressive episode: A case report

Encéphale, 2024-10, Vol.50 (5), p.583-584

2024

Volltextzugriff (PDF)

Amantadine‐induced hypersexuality in a non‐Parkinsonian patient with catatonia: a case report

Psychiatry and clinical neurosciences, 2023-10, Vol.77 (10), p.573-574

2023

Volltextzugriff (PDF)

Unlike other medical conditions, type 2 diabetes is a risk factor for new-onset major depression after COVID-19

Journal of psychosomatic research, 2024-12, Vol.187, p.111963, Article 111963

2024

Volltextzugriff (PDF)

Meta-analysis of central and peripheral [gamma]-aminobutyric acid levels in patients with unipolar and bipolar depression

Journal of psychiatry & neuroscience, 2018-01, Vol.43 (1), p.58

2018

Volltextzugriff (PDF)

Intranasal (R, S)-ketamine delivery induces sustained antidepressant effects associated with changes in cortical balance of excitatory/inhibitory synaptic activity

Neuropharmacology, 2023-03, Vol.225, p.109357-109357, Article 109357

2023

Volltextzugriff (PDF)

Intra-nasal esketamine induced psychotic disorder in a post COVID-19 major depressive episode: A case reportTrouble psychotique induit par l eskétamine intra-nasale dans un épisode dépressif majeur post-COVID-19: un cas clinique

Encéphale, 2024, Vol.50 (5), p.583-584

2024

Volltextzugriff (PDF)

Hydroxychloroquine, Interleukin-6 Receptor Antagonists and Corticoid Treatments of Acute COVID-19 Infection: Psychiatric Symptoms and Mental Disorders 4 Months Later

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2022-11, Vol.20 (4), p.762-767

2022

Volltextzugriff (PDF)

Acute Objective Severity of COVID-19 Infection and Psychiatric Disorders 4 Months After Hospitalization for COVID-19

The journal of clinical psychiatry, 2021-11, Vol.83 (1)

2021

Volltextzugriff (PDF)

Efficacy and safety of dopamine agonists in patients treated with antipsychotics and presenting a macroprolactinoma

European journal of endocrinology, 2020-08, Vol.183 (2), p.221-231

2020

Volltextzugriff (PDF)

Antidepressant short-term and long-term brain effects during self-referential processing in major depression

Psychiatry research. Neuroimaging, 2016-01, Vol.247, p.17-24

2016

Volltextzugriff (PDF)

Resistant Catatonia in a High-Functioning Autism Spectrum Disorder Patient Successfully Treated with Amantadine

Journal of child and adolescent psychopharmacology, 2015-11, Vol.25 (9), p.726-726

2015

Volltextzugriff (PDF)

Telepsychiatry in the Post-COVID-19 Era: Moving Backwards or Forwards?

Psychotherapy and psychosomatics, 2020-12, Vol.90 (1), p.69-70

2020

Volltextzugriff (PDF)

Lower plasma vascular endothelial growth factor A in major depressive disorder not normalized after antidepressant treatment: A case control study

Australian and New Zealand journal of psychiatry, 2020-04, Vol.54 (4), p.402-408

2020

Volltextzugriff (PDF)

Time-Course of Depression Improvement With Ketamine Adjunction in Electroconvulsive Therapy

The journal of ECT, 2016-06, Vol.32 (2), p.80-81

2016

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(30)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(21)
Science & Technology
(21)
Humans
(13)
Psychiatry
(13)
Life Sciences
(12)
Neurosciences & Neurology
(8)
Adult
(7)
Covid-19
(7)
Female
(7)
Male
(6)
Middle Aged
(6)
Clinical Neurology
(5)
Neurosciences
(5)
Aged
(4)
Major Depressive Disorder
(4)
Pharmacology & Pharmacy
(4)
Treatment Outcome
(4)
Depression
(3)
Depressive Disorder, Major - Drug Therapy
(3)
Double-Blind Method
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19

Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression

Short‐term acceptability by patients and psychiatrists of the turn to psychiatric teleconsultation in the context of the COVID‐19 pandemic

Efficacy and safety of adjunctive vagus nerve stimulation in the treatment of resistant depression with psychotic features: A case report

Dramatic and Rapid Resolution of Both Psychosis and Neuroleptic-Related Catatonia With Zolpidem in a Patient With Systemic Lupus Erythematosus

Neurobiological Approach of Catatonia and Treatment Perspectives

Meta-analysis of central and peripheral γ-aminobutyric acid levels in patients with unipolar and bipolar depression

Comorbidity of long COVID and psychiatric disorders after a hospitalisation for COVID-19: a cross-sectional study

Anosmia during acute COVID-19 and psychiatric outcomes 4 months later: Results from the prospective COMEBAC cohort

P124. Which Patients Will Have Mental Disorders After Hospitalization for COVID-19?

Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial

Intra-nasal esketamine induced psychotic disorder in a post COVID-19 major depressive episode: A case report

Amantadine‐induced hypersexuality in a non‐Parkinsonian patient with catatonia: a case report

Unlike other medical conditions, type 2 diabetes is a risk factor for new-onset major depression after COVID-19

Meta-analysis of central and peripheral [gamma]-aminobutyric acid levels in patients with unipolar and bipolar depression

Intranasal (R, S)-ketamine delivery induces sustained antidepressant effects associated with changes in cortical balance of excitatory/inhibitory synaptic activity

Intra-nasal esketamine induced psychotic disorder in a post COVID-19 major depressive episode: A case reportTrouble psychotique induit par l eskétamine intra-nasale dans un épisode dépressif majeur post-COVID-19: un cas clinique

Hydroxychloroquine, Interleukin-6 Receptor Antagonists and Corticoid Treatments of Acute COVID-19 Infection: Psychiatric Symptoms and Mental Disorders 4 Months Later

Acute Objective Severity of COVID-19 Infection and Psychiatric Disorders 4 Months After Hospitalization for COVID-19

Efficacy and safety of dopamine agonists in patients treated with antipsychotics and presenting a macroprolactinoma

Antidepressant short-term and long-term brain effects during self-referential processing in major depression

Resistant Catatonia in a High-Functioning Autism Spectrum Disorder Patient Successfully Treated with Amantadine

Telepsychiatry in the Post-COVID-19 Era: Moving Backwards or Forwards?

Lower plasma vascular endothelial growth factor A in major depressive disorder not normalized after antidepressant treatment: A case control study

Time-Course of Depression Improvement With Ketamine Adjunction in Electroconvulsive Therapy

Suchergebnisse filtern